Abiopharma

Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026

Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer

(19% Negative) ImmunityBio Inc (IBRX) Announces Delay in million Trials for situ (NMIBC CIS) Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations

(90% Positive) Ocugen Inc. (OCGN) Announces Clinical Development Update

HCA Healthcare - HCA Healthcare Names Erica Rossitto as Chief Nurse Executive

GT Biopharma Announces IND Submission for GTB-5550TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers

Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR

Zydus Lifesciences Limited completes the acquisition of Agenus Inc.s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.

Hoth Therapeutics Notification (HOTH)

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Neufeld Leah R 🟢 acquired 2.6K shares of Immuneering Corp (IMRX) at $4.15 Transaction Date: Jan 13, 2026 | Filing ID: 000010

Cognex Corporation - Cognex Announces Fourth Quarter 2025 Earnings Release and Conference Call Dates

enVVeno Medical Announces Reverse Stock Split

Cognex Announces Fourth Quarter 2025 Earnings Release and Conference Call Dates

Curaleaf Celebrates Opening of Lauderhill, Florida Dispensary